10-Q | 2020-09-30 | Filed 2020-11-16 |
10-Q | 2020-06-30 | Filed 2020-08-12 |
10-Q | 2020-03-31 | Filed 2020-05-15 |
10-K | 2019-12-31 | Filed 2020-03-30 |
S-1 | 2019-10-18 | Public Filing |
8-K | 2020-03-23 | |
8-K | 2020-01-30 | |
8-K | 2019-12-17 | |
8-K | 2019-11-19 | |
8-K | 2019-11-07 |
Comps ($ TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|---|---|---|
Link Motion (LKM) | 0 | 0% | 853,628,000,000 | 377,864,000,000 | 0 | 0 | 0 | 0 | -91,397,001,000 | ||
Dais Analytic (DLYT) | 0 | 36% | 0.0 | -597% | 413,706,000 | 8,699,663,000 | 1,055,259,000 | 377,909,000 | -2,469,890,000 | -2,184,371,000 | -13,775,000 |
Dominovas Energy (DNRG) | |||||||||||
Jumia (JMIA) | |||||||||||
Cerence (CRNC) | |||||||||||
Visium Technologies (VISM) | 0 | 0.0 | -31,116% | 2,558,000 | 3,140,777,000 | 0 | 0 | -795,949,000 | -795,949,000 | -2,559,000 | |
Renewable Energy Acquisition (REAC) | 0 | 0.0 | 2,353,600% | 0 | 0 | -23,536,000 | -21,806,000 | -1,000 | |||
Headhunter Group (HHR) | |||||||||||
Endonovo Therapeutics (ENDV) | 0 | 73% | -0.8 | -301% | 3,413,615,000 | 19,979,611,000 | 203,851,000 | 149,574,000 | -10,267,853,000 | -9,617,427,000 | 7,447,616,000 |
InMode (INMD) | |||||||||||
Rich Pharmaceuticals (RCHA) | 0 | -6% | 0.0 | -4,521% | 37,429,000 | 6,396,089,000 | 115,000,000 | -6,625,000 | -1,692,341,000 | -2,355,974,000 | -6,223,000 |
Granite Real Estate (GRP) | |||||||||||
W&E Source (WESC) | 0 | 100% | 0.0 | -419% | 14,314,000 | 182,161,000 | 527,000 | 527,000 | -60,006,000 | -60,006,000 | -2,931,000 |
Growlife (PHOT) | 0 | 33% | 0.0 | -130% | 4,625,508,000 | 9,063,884,000 | 6,743,804,000 | 2,192,581,000 | -6,029,017,000 | -4,694,925,000 | -201,073,000 |
Arete Industries (ARET) | |||||||||||
Juniper Industrial (JIH) | |||||||||||
Sundial Growers (SNDL) | |||||||||||
PositiveID Corp (PSID) | |||||||||||
US Stem Cell (USRM) | 0 | 58% | -0.2 | -481% | 656,240,000 | 9,770,052,000 | 2,763,385,000 | 1,597,926,000 | -3,158,293,000 | -2,255,964,000 | 378,392,000 |
Fiverr (FVRR) |
Balance Sheet ($) | ||
Cash | ||
Accounts Receivable | ||
Inventory | ||
PP&E | ||
Assets | ||
Accounts Payable | ||
Long-Term Debt | ||
Liabilities | ||
Stockholders' Equity | ||
Income Statement ($) | ||
Revenue | ||
Cost of Revenue | ||
Gross Profit | ||
R&D | ||
SG&A | ||
Tax | ||
Net Income | ||
Cash Flow ($) | ||
Cash Operating | ||
Cash Investing | ||
Cash Financing |